This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Enzo Biochem, Inc.
Drug Names(s): EHT899
Description: EHT899 is a proprietary oral formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It may also enhance a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load.
Pink Sheet Hepatitis B Therapeutics
Pink Sheet Weekly Trademark Review September 10, 2013
Additional information available to subscribers only: